Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease

Children's Hospital of Eastern Ontario Research Institute Inc

$48,450.00

Variation in the care of elderly-onset inflammatory bowel disease

EF 2015-16

Résumé
Approximately 1 in 150 Canadians are living with inflammatory bowel disease. Canada has one of the highest rates of IBD in the world and they are continuing to increase. This is especially true among Canadians over age 65. There are two types of IBD: Crohn's disease and ulcerative colitis. Both diseases cause inflammation and ulcers to develop in the gastrointestinal system and follow unpredictable patterns of active disease and remission. During periods of active disease (flares), patients experience debilitating abdominal pain, diarrhea, and fatigue. Medications can be used to put the disease into remission. Older Canadians with IBD living in rural parts of Canada have less access to gastroenterologists and are more likely to visit the emergency department and be hospitalized. This project will look for variation in how patients over the age of 65 with IBD are treated in different parts of Canada. We will then look to see if the differences in treatment are associated with an increased need for hospitalization and surgery. We will use databases that include information on physician billing, prescriptions, and hospital discharge summaries from 6 Canadian provinces (Alberta, Manitoba, Ontario, Quebec, Nova Scotia, and Saskatchewan). We will analyze data from each province separately and then combine the results to understand differences in treatment and the disease severity across Canada.
Programme
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
339995
Name
Kuenzig M. Ellen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Crohn's and Colitis Canada (Toronto, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Variation in the care of elderly-onset inflammatory bowel disease
Programtype2
Fellowship Programs
Orgnameinp2
Children's Hospital of Eastern Ontario Research Institute Inc
Cihramount2
$48,450
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Administrative Data; Crohn'S Disease; Environmental Risk Factors; Inflammatory Bowel Disease; Ulcerative Colitis; Very-Early Onset Inflammatory Bowel Disease
Abstract
Approximately 1 in 150 Canadians are living with inflammatory bowel disease. Canada has one of the highest rates of IBD in the world and they are continuing to increase. This is especially true among Canadians over age 65. There are two types of IBD: Crohn's disease and ulcerative colitis. Both diseases cause inflammation and ulcers to develop in the gastrointestinal system and follow unpredictable patterns of active disease and remission. During periods of active disease (flares), patients experience debilitating abdominal pain, diarrhea, and fatigue. Medications can be used to put the disease into remission. Older Canadians with IBD living in rural parts of Canada have less access to gastroenterologists and are more likely to visit the emergency department and be hospitalized. This project will look for variation in how patients over the age of 65 with IBD are treated in different parts of Canada. We will then look to see if the differences in treatment are associated with an increased need for hospitalization and surgery. We will use databases that include information on physician billing, prescriptions, and hospital discharge summaries from 6 Canadian provinces (Alberta, Manitoba, Ontario, Quebec, Nova Scotia, and Saskatchewan). We will analyze data from each province separately and then combine the results to understand differences in treatment and the disease severity across Canada.
Competitiondate
201511
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Kuenzig, M. Ellen
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $48,450~ $0~